News & Updates

In breast cancer survivors receiving aromatase inhibitors, vulvovaginal fractional carbon dioxide (CO2) laser therapy (CLT) does not appear to confer additional improvements in sexual or vaginal health outcomes, as shown in a study.

In children receiving myelosuppressive chemotherapy for cancer, prophylactic treatment with romiplostim helps reduce bleeding and the need for blood transfusion despite having no effect on the speed of platelet recovery, as shown in a study.

A gamified tool dubbed ChemINJ offers a playful approach to improving knowledge on the preparation of anticancer medications, according to a study, which suggests its integration into student curricula.

The use of axitinib in combination with pembrolizumab demonstrates efficacy in the treatment of metastatic renal cell carcinoma (mRCC), according to a real-world study.

First-line treatment with ivonescimab significantly improves overall survival (OS) in patients with PD-L1-positive (PD-L1+) locally advanced or metastatic nonsmall cell lung cancer (NSCLC) compared with pembrolizumab, according to a prespecified interim analysis of the phase III HARMONi-2 trial presented at WCLC 2026.

First-line treatment with carboplatin/paclitaxel (CP), with or without radiotherapy, is not associated with improvements in survival among patients with anaplastic thyroid cancer (ATC), as shown in a study.